VBI VACCINES INC's ticker is VBIV and the CUSIP is 91790E102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $43,000 | -12.2% | 12,484 | 0.0% | 0.04% | -9.8% |
| Q2 2016 | $49,000 | -14.0% | 12,484 | -48.4% | 0.04% | -12.8% |
| Q1 2016 | $57,000 | -3.4% | 24,205 | 0.0% | 0.05% | +30.6% |
| Q4 2015 | $59,000 | -6.3% | 24,205 | +0.9% | 0.04% | -12.2% |
| Q3 2015 | $63,000 | 0.0% | 24,000 | 0.0% | 0.04% | +7.9% |
| Q2 2015 | $63,000 | +1.6% | 24,000 | 0.0% | 0.04% | 0.0% |
| Q1 2015 | $62,000 | -22.5% | 24,000 | 0.0% | 0.04% | -24.0% |
| Q4 2014 | $80,000 | +1.3% | 24,000 | 0.0% | 0.05% | -10.7% |
| Q3 2014 | $79,000 | – | 24,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clarus Ventures, LLC | 4,971,091 | $12,129,000 | 8.50% |
| Perceptive Advisors | 3,260,356 | $7,955,000 | 0.59% |
| Cambridge Investment Research Advisors, Inc. | 1,433,100 | $3,497,000 | 0.08% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 27,556 | $67,000 | 0.07% |
| Sigma Investment Management Co | 24,205 | $59,000 | 0.04% |
| UBS Group AG | 3,937 | $10,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 63,322 | $149,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,219 | $3,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 23,050 | $56,000 | 0.00% |
| MORGAN STANLEY | 1,470 | $3,000 | 0.00% |